Association of TGF-β signaling in angiotensin II-induced PAI-1 mRNA upregulation in mesangial cells: Role of PKC

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1449, Issue 3, 1999, Pages 217-226

  Motojima, Masaru ^a   Kakuchi, Junji ^a   Yoshioka, Toshimasa ^b  

^a KUREHA CORPORATION   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Angiotensin II; Mesangial cell; Plasminogen activator inhibitor type 1; Protein kinase C; Signal transduction; Transforming growth factor

Indexed keywords

1 [N,O BIS(5 ISOQUINOLINESULFONYL) N METHYLTYROSYL] 4 PHENYLPIPERAZINE; ANGIOTENSIN; BISINDOLYLMALEIMIDE; CALCIUM IONOPHORE; GENISTEIN; IONOMYCIN; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENTIATION; GENE EXPRESSION; MALE; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANGIOTENSIN II; ANIMALS; CELLS, CULTURED; DRUG SYNERGISM; GENE EXPRESSION REGULATION; GENISTEIN; GLOMERULAR MESANGIUM; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN KINASE C; RATS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 0032961960     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4889(99)00014-2     Document Type: Article

References (39)

1. Gibbons G.H., Pratt R.E., Dzau V.J. Vascular smooth muscle cell hypertrophy versus hyperplasia: autocrine transforming growth factor-β 1 expression determines growth response to angiotensin II. J. Clin. Invest. 90:1992;456-461.
2. Weber H., Taylor D.S., Molloy C.J. Angiotensin II induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells: correlation with the expression of specific growth factors and reversal by suramin. J. Clin. Invest. 93:1994;788-798.
3. Ray P.E., Bruggeman L.A., Horikoshi S., Aguilera G., Klotman P.E. Angiotensin II stimulates human fetal mesangial cell proliferation and fibronectin synthesis by binding to AT1 receptors. Kidney Int. 45:1994;177-184.
4. Wolf G., Haberstroh U., Neilson E.G. Angiotensin II stimulates biosynthesis of type I collagen in cultured murine mesangial cells. Am. J. Pathol. 140:1992;95-107.
5. R. Morishita, J. Higaki, M. Miyazaki, T. Ogihara, Possible role of the vascular renin-angiotensin system in hypertension and vascular hypertrophy, Hypertension 19 (1992) II-62-II-67 (Suppl. II).
6. Ichikawa I., Harris R.C. Angiotensin actions in the kidney: renewed insight into the old hormone. Kidney Int. 40:1991;583-596.
7. Timmermans P.B.M.W.M., Wong P.C., Chiu A.T., Herblin W.F., Benfield P., Carini D.J., Lee R.J., Wexler R.R., Saye J.A.M., Smith R.D. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol. Rev. 45:1993;205-251.
8. Alexander R.W., Brock T.A., Gimbrone M.A., Rittenhouse S.L. Angiotensin II increases inositol triphosphate and calcium in vascular smooth muscle cells. Hypertension. 7:1985;447-451.
9. Berridge M.J. Inositol triphosphate and diacylglycerol: two interacting second messengers. Annu. Rev. Biochem. 56:1987;159-193.
10. Marrero M.B., Paxton W.G., Duff J.L., Berk B.C., Bernstein K.E. Angiotensin II stimulates tyrosine phosphorylation of phospholipase C-γ1 in vascular smooth muscle cells. J. Biol. Chem. 269:1994;10935-10939.
11. Eguchi S., Matsumoto T., Motley E.D., Utsunomiya H., Inagami T. Identification of an essential signaling cascade for mitogen-activated protein kinase activation by angiotensin II in cultured rat smooth muscle cells. J. Biol. Chem. 271:1996;14169-14175.
12. Marrero M.B., Schieffer B., Paxton W.G., Heerdt L., Berk B.C., Delafontaine P., Bernstein K.E. Direct stimulation of JAK/STAT pathway by the angiotensin II AT1 receptor. Nature. 375:1995;247-250.
13. Baricos W.H., Cortez S.L., El-Dahr S.S., Schnaper H.W. ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade. Kidney Int. 47:1995;1039-1047.
14. Tomooka S., Border W.A., Marshall B.C., Noble N.A. Glomerular matrix accumulation is linked to inhibition of the plasmin protease system. Kidney Int. 42:1992;1462-1469.
15. Kagami S., Kuhara T., Okada K., Kuroda Y., Border W.A., Noble N.A. Dual effects of angiotensin II on the plasminogen/plasmin system in rat mesangial cells. Kidney Int. 51:1997;664-671.
16. Anderson P.W., Zhang X.Y., Tian J., Correale J.D., Xi X.P., Yang D., Graf K., Law R.E., Hsueh W.A. Insulin and angiotensin II are additive in stimulating TGF-β1 and matrix mRNAs in mesangial cells. Kidney Int. 50:1996;745-753.
17. Kagami S., Border W.A., Miller D.E., Noble N.A. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J. Clin. Invest. 93:1994;2431-2437.
18. Hiraoka-Yoshimoto M., Higashida K., Takeda M., Kawamoto S., Ichikawa I., Hoover R.L. Characterization of myosin heavy and light chains in cultured mesangial cells. Kidney Int. 40:1991;1013-1019.
19. Seal E.E., Eaton D.C., Gomez L.M., Ma H., Ling B.N. Extracellular glucose reduces the responsiveness of mesangial cell ion channels to angiotensin II. Am. J. Physiol. 269:1995;F389-F397.
20. Chansel D., Czekalski S., Pham P., Ardaillou R. Characterization of angiotensin II receptor subtypes in human glomeruli and mesangial cells. Am. J. Physiol. 262:1992;F432-F441.
21. Toullec D., Pianetti P., Coste H., Bellevergue P., Grand-Perret T., Ajakane M., Baudet V., Boissin P., Boursier E., Loriolle F., Duhamel L., Charon D., Kirilovsky J. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266:1991;15771-15781.
22. 2+/calmodulin-dependent protein kinase II. J. Biol. Chem. 265:1990;4315-4320.
23. Earp H.S., Huckle W.R., Dawson T.L., Li X., Graves L.M., Dy R. Angiotensin II activates at least two tyrosine kinases in rat liver epithelial cells. J. Biol. Chem. 270:1995;28440-28447.
24. Molloy C.J., Taylor D.S., Weber H. Angiotensin II stimulation of rapid protein tyrosine phosphorylation and protein kinase activation in rat aortic smooth muscle cells. J. Biol. Chem. 268:1993;7338-7345.
25. Akiyama T., Ogawara H. Use and specificity of genistein as inhibitor of protein-tyrosine kinases. Methods Enzymol. 201:1991;362-370.
26. Shin S., Fujiwara Y., Wada A., Takama T., Orita Y., Kamada T., Togawa K. Angiotensin II-induced increase in inositol 1,4,5-triphosphate in cultured rat mesangial cells: evidence by refined high performance liquid chromatography. Biochem. Biophys. Res. Commun. 142:1987;70-77.
27. src at a novel site. Cell. 42:1985;849-857.
28. Pendergast A.M., Traugh J.A., Witte O.N. Normal cellular and transformation-associated abl proteins share common sites for protein kinase C phosphorylation. Mol. Cell. Biol. 7:1987;4280-4289.
29. Kolch W., Heidecker G., Kochs G., Hummel R., Vahidi H., Mischak H., Finkenzeller G., Marme D., Rapp U.R. Protein kinase Cα activates Raf-1 by direct phosphorylation. Nature. 364:1993;249-252.
30. src in vascular smooth muscle cells. Circ. Res. 77:1995;1053-1059.
31. Wilson H.M., Haites N.E., Booth N.A. Opposing effects of interleukin-1 and TGF-beta on the regulation of tissue-type plasminogen activator and plasminogen activator inhibitor type-1 expression by human mesangial cells. Exp. Nephrol. 5:1997;233-238.
32. Reilly C.F., McFall R.C. Platelet-derived growth factor and transforming growth factor-β regulate plasminogen activator inhibitor-1 synthesis in vascular smooth muscle cells. J. Biol. Chem. 266:1991;9419-9427.
33. Border W.A., Noble N.A. Transforming growth factor-β in tissue fibrosis. New Engl. J. Med. 331:1994;1286-1292.
34. Yamamoto T., Noble N.A., Cohen A.H., Nast C.C., Hishida A., Gold L.I., Border W.A. Expression of transforming growth factor-β isoforms in human glomerular diseases. Kidney Int. 49:1996;461-469.
35. Arts J., Grimbergen J., Bosma P.J., Rahmsdorf H.J., Kooistra T. Role of c-Jun and proximal phorbol 12-myristate-13-acetate-(PMA)-responsive elements in the regulation of basal and PMA-stimulated plasminogen-activator inhibitor-1 gene expression in HepG2. Eur. J. Biochem. 241:1996;393-402.
36. Knudsen H., Olesen T., Riccio A., Ungaro R., Christensen L., Andreasen P.A. A common response element mediates differential effects of phorbol esters and forskolin on type-1 plasminogen activator inhibitor gene expression in human breast carcinoma cells. Eur. J. Biochem. 220:1994;63-74.
37. Sandler M.A., Zhang J.-N., Westerhausen D.R. Jr., Billadello J.J. A novel protein interacts with the major transforming growth factor-β responsive element in the plasminogen activator inhibitor type-1 gene. J. Biol. Chem. 269:1994;21500-21504.
38. Dennler H., Itoh S., Vivien D., Dijke P., Huet S., Gauthier J.-M. Direct binding of Smad3 and Smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17:1998;3091-3100.
39. Shibuya S., Yamaguchi K., Shirakabe K., Tonegawa A., Gotoh Y., Ueno N., Irie K., Nishida E., Matsumoto K. TAB1: an activator of the TAK1 MAPKKK in TGF-β Signal transduction. Science. 272:1996;1179-1182.